{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:32:40Z","timestamp":1778747560701,"version":"3.51.4"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T00:00:00Z","timestamp":1137456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>\n                      To investigate the pharmacology and functionality of \u03b1\n                      <jats:sub>1<\/jats:sub>\n                      \u2010adrenoceptors in human corpus cavernosum, and to determine the predominant subtype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>\n                      Cavernosal tissue specimens were obtained from the penises of 22 men (mean age 37.4\u2003years) removed during gender re\u2010assignment surgery. The men had been maintained on long\u2010term oestrogen therapy before surgery, to aid the development of secondary feminine characteristics (oestrogen treatments were stopped 6\u2003weeks before surgery). Corpus cavernosum strips were mounted in organ baths perfused with Krebs\u2019 solution. A control concentration\u2010response curve (CRC) to phenylephrine (a nonselective \u03b1\n                      <jats:sub>1<\/jats:sub>\n                      \u2010agonist) was obtained. Then the tissues were incubated with the \u03b1\n                      <jats:sub>1A<\/jats:sub>\n                      antagonist, WB4101; the \u03b1\n                      <jats:sub>1B<\/jats:sub>\n                      antagonist, chloroethylclonidine; or the \u03b1\n                      <jats:sub>1D<\/jats:sub>\n                      antagonist BMY\u20037378 (all at 1\u2003\u00b5\n                      <jats:sc>m<\/jats:sc>\n                      ) and the CRC to phenylephrine was repeated. The concentration producing a half\u2010maximal response (EC\n                      <jats:sub>50<\/jats:sub>\n                      ) and p\n                      <jats:italic>K<\/jats:italic>\n                      <jats:sub>B<\/jats:sub>\n                      values (logarithm of the dissociation constant, a measure of affinity) were determined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      WB4101 produced a parallel rightward shift of the CRC to phenylephrine, with a p\n                      <jats:italic>K<\/jats:italic>\n                      <jats:sub>B<\/jats:sub>\n                      of 7.49. BMY\u20037378 also produced a parallel rightward shift of the CRC to phenylephrine with a p\n                      <jats:italic>K<\/jats:italic>\n                      <jats:sub>B<\/jats:sub>\n                      of 6.45. Chloroethylclonidine had a similar effect on the phenylephrine CRC, with a p\n                      <jats:italic>K<\/jats:italic>\n                      <jats:sub>B<\/jats:sub>\n                      of 5.90.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>\n                      \u03b1\n                      <jats:sub>1<\/jats:sub>\n                      \u2010adrenoceptors in human cavernosal tissue have a relatively low affinity for BMY\u20037378 and chloroethylclonidine, but are more sensitive to WB4101. This confirms that the predominant \u03b1\n                      <jats:sub>1<\/jats:sub>\n                      \u2010adrenoceptor subtype in human corpus cavernosum is the \u03b1\n                      <jats:sub>1A<\/jats:sub>\n                      subtype and this might help in developing more selective antagonists and agonists for managing erectile dysfunction and priapism.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2006.05956.x","type":"journal-article","created":{"date-parts":[[2006,1,17]],"date-time":"2006-01-17T06:29:33Z","timestamp":1137479373000},"page":"329-332","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["\u03b1\n                    <sub>1<\/sub>\n                    \u2010Adrenoceptor subtypes in isolated corporal tissue from patients undergoing gender re\u2010assignment"],"prefix":"10.1111","volume":"97","author":[{"given":"OSAMA M.","family":"EL\u2010GAMAL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAVINDER P.S.","family":"SANDHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIM","family":"TERRY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RUTH A.","family":"ELLIOTT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,17]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"71","article-title":"Pharmacotherapy of erectile dysfunction: a review","volume":"1","author":"Junemann KP","year":"1989","journal-title":"Int J Impotence Res"},{"key":"e_1_2_7_3_2","first-page":"155","article-title":"Pharmacology of drugs used for treatment of erectile dysfunction and priapism","volume":"3","author":"Andersson KE","year":"1991","journal-title":"Int J Impotence Res"},{"key":"e_1_2_7_4_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-5347(17)37781-9","article-title":"Treatment of pharmacological priapism with phenylephrine","volume":"146","author":"Dittrich A","year":"1991","journal-title":"J Urol"},{"key":"e_1_2_7_5_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000464011","article-title":"Intracorporeal self\u2010injection with epinephrine as treatment of idiopathic recurrent priapism","volume":"17","author":"Van Driel MF","year":"1990","journal-title":"Eur Urol"},{"key":"e_1_2_7_6_2","volume-title":"IUPHAR Compendium of Receptor Characterization and Classification","author":"Bylund DB","year":"1998"},{"issue":"2","key":"e_1_2_7_7_2","first-page":"A42","article-title":"Subclassification of alpha\u20101 adrenoceptors in porcine smooth muscle of corpus cavernosum","volume":"4","author":"Wagner G","year":"1992","journal-title":"Int J Impotence Res"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.71.325"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3900348"},{"key":"e_1_2_7_10_2","first-page":"285A","article-title":"Alpha\u20101 adrenergic receptors subtype mRNA expression in human corpus cavernosum","volume":"149","author":"Price DT","year":"1993","journal-title":"J Urol"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13534.x"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-199501000-00081"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(97)00388-1"},{"key":"e_1_2_7_14_2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0026-895X(25)13030-7","article-title":"Heterogeneity of alpha 1\u2010adrenergic receptors revealed by chloroethylclonidine","volume":"32","author":"Han C","year":"1987","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_15_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0026-895X(25)13358-0","article-title":"Comparison of alpha 1\u2010adrenergic receptors subtypes distinguished by chloroethylclonidine and WB4101","volume":"33","author":"Minneman KP","year":"1988","journal-title":"Mol Pharmacol"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-3623(96)00187-5"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00109-5"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.09.046"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000145589.85559.90"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)00751-R"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68240-7"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220628"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/002215540405200306"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-003-0371-y"},{"key":"e_1_2_7_25_2","first-page":"1449","article-title":"Estrogen replacement modulates resistance artery smooth muscle and endothelial alpha2\u2010adrenoceptor reactivity","volume":"6","author":"Ferrer M","year":"2004","journal-title":"Life Sci"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1566-0702(02)00066-8"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0962"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.140.4.6655"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.1997.tb01873.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.06.062"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901050"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2006.05956.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2006.05956.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:42:40Z","timestamp":1761727360000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2006.05956.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,17]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1111\/j.1464-410X.2006.05956.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2006.05956.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,17]]},"assertion":[{"value":"2006-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}